Syntocinon for Prolonged Grief Disorder; Bereavement
This study is completed in the United States. It is testing syntocinon for Prolonged Grief Disorder; Bereavement.
Prolonged grief disorder, BereavementDrugFrom 55 Years to 80 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether a digital tool or app may be useful for adults experiencing prolonged grief disorder.
What would participation involve?
Participants may use a digital tool or app, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with prolonged grief disorder.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
